Ulandelelwano lwexesha elide lwe-COVID-19

UJennifer Mihas wayedla ngokuphila ubomi obusebenzayo, edlala i-tennis kunye nokuhambahamba e-Seattle.Kodwa ngoMatshi ka-2020, wavavanywa ukuba une-COVID-19 kwaye ebegula ukusukela ngoko.Ngoku wayedinwe ediniwe kukuhamba amakhulu eeyadi, kwaye wayephethwe ngumphefumlo, intloko ebuhlungu, i-arrhythmias kunye nezinye iimpawu ezibuthathaka.

Ezi ayizomeko zodwa.NgokwaMaziko aseMelika oLawulo lweSifo kunye noThintelo, i-10 ukuya kwi-30 yeepesenti yabantu abosulelwe yi-SARS-CoV-2 bafumana iingxaki zempilo ixesha elide.Uninzi lwazo ezinje ngeMihas, ezi mpawu zithe gqolo, ezaziwa njengee-acute sequelae yosulelo lwe-SARS-CoV-2 (PASC) okanye, ngakumbi, ukulandelana kwexesha elide le-COVID-19, inobulali okanye ibenzima ngokwaneleyo ukuba ikhubazeke, echaphazela phantse nayiphi na inkqubo yamalungu emzimbeni.

news-2

Abantu abachaphazelekayo bahlala bechaza ukudinwa okugqithisileyo kunye neentlungu zomzimba.Abantu abaninzi baphelelwa sisiva sokungcamla okanye sokujoja, iingqondo zabo ziyacotha kwaye abakwazi kugxila, nto leyo yingxaki eqhelekileyo.Iingcali zixhalabile ukuba ezinye izigulana ezine-sequelae yexesha elide ye-COVID-19 zinokungaze ziphile.

Ngoku, i-sequelae yexesha elide ye-COVID-19 iya isanda kwindawo ebonakalayo.NgoFebruwari, amaZiko eSizwe ezeMpilo abhengeze inyathelo le-1.15 yeebhiliyoni zeedola ukufumanisa oonobangela bokulandelana kwexesha elide le-COVID-19 kunye nokufumana iindlela zokuthintela kunye nokunyanga esi sifo.

Ukusukela ekupheleni kukaJuni, bangaphezulu kwe-180 lezigidi abantu abaye bavavanywa ukuba banayo i-SARS-CoV-2, kwaye amakhulu ezigidi ngaphezulu kusenokwenzeka ukuba bosulelwe yi-SARS-CoV-2, kusenziwa amayeza amatsha ukujongana nenani elikhulu labantu. Izalathisi ezintsha ezinokubakho kwezamayeza.

I-PureTech Health iqhuba ulingo lwekliniki lwesigaba sesi-II sohlobo olukhutshwayo lwe-pirfenidone, i-LYT-100.I-Pirfenidone ivunyiwe kwi-idiopathic pulmonary fibrosis.Iithagethi ze-Lyt-100 ze-pro-inflammatory cytokines, kuquka i-IL-6 kunye ne-TNF-α, kwaye iyanciphisa i-TGF-β ukubonakaliswa ukuvimba ukuchithwa kwe-collagen kunye nokwakheka kwesiva.

I-CytoDyn ivavanya i-CC motactic chemokine receptor 5 (CCR5) i-leronlimab, i-IgG4 ye-monoclonal antibody yomntu, kwisigaba sesi-2 solingo lwabantu abangama-50.I-CCR5 ibandakanyeka kwiinkqubo ezininzi zezifo, kuquka i-HIV, i-multiple sclerosis, kunye nomhlaza we-metastatic.I-Leronlimab iye yavavanywa kwisigaba 2B/3 solingo lwezonyango njengonyango olongezelelweyo lwesifo sokuphefumla kwizigulana ezigula kakhulu ezine-COVID-19.Iziphumo zibonisa ukuba ichiza linenzuzo yokusinda xa kuthelekiswa nonyango oluqhelekileyo olusetyenziswayo, kwaye uphononongo lwangoku lwesigaba sesi-2 luya kuphanda ichiza njengonyango loluhlu olubanzi lweempawu.

I-Ampio Pharmaceuticals inike ingxelo yeziphumo ezihle zesigaba soku-1 se-cyclopeptide i-LMWF5A (i-aspartic alanyl diketopiperazine), enyanga ukudumba okugqithisileyo kwimiphunga, kwaye i-Ampio ithi i-peptide yonyusa yonke into ebangela ukufa kwizigulana ezinoxinzelelo lokuphefumla.Kulingo olutsha lweSigaba soku-1, abaguli abaneempawu zokuphefumla ezithatha iiveki ezine okanye ngaphezulu baya kuzenzela ngokwabo ekhaya nge-nebulizer iintsuku ezintlanu.

I-Synairgen e-United Kingdom isebenzise indlela efanayo yokongeza ixesha elide le-COVID-19 sequelae kwisigaba sesi-3 solingo lwezonyango lwe-SNG001 (i-IFN-β ephefumlelweyo).Iziphumo ezivela kwisigaba se-2 sophando lweziyobisi zibonise ukuba i-SNG001 yayiluncedo ekuphuculeni isigulane, ukubuyisela, kunye nokukhutshwa xa kuthelekiswa ne-placebo ngosuku lwe-28.


Ixesha lokuthumela: 26-08-21